FOXC2 and breast cancer: In breast cancer, Mani and colleagues reported that the overexpression of Twist, Snail or FOXC2 not only made the breast cancer cells with more mesenchymal properties, but also with an increased expression of CD44+/CD24-/low breast CSC markers and an increased mammosphere forming efficiency [18, 103].